Thrombocytopenia associated with second-line carboplatin-based chemotherapy for ovarian, fallopian tube, and primary peritoneal cavity cancers

被引：0
|
作者：
Maurie Markman
Jon Markman
Kenneth Webster
Kristine Zanotti
Barbara Kulp
Gertrude Peterson
Jerome Belinson
机构：
[1] University of Texas M.D. Anderson Cancer Center ,Departments of Hematology/Medical Oncology and Gynecology/Obstetrics
[2] The Cleveland Clinic Foundation,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2004年 / 130卷
关键词：
Thrombocytopenia; Carboplatin; Ovarian cancer; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：741 / 744
页数：3
相关论文
共 50 条
  • [31] Increased Incidence of Severe Gastrointestinal Events With First-Line Paclitaxel, Carboplatin, and Vorinostat Chemotherapy for Advanced-Stage Epithelial Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
    Mendivil, Alberto A.
    Micha, John P.
    Brown, John V., III
    Rettenmaier, Mark A.
    Abaid, Lisa N.
    Lopez, Katrina L.
    Goldstein, Bram H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (03) : 533 - 539
  • [32] Safety and Efficacy of Video Laparoscopic Surgical Debulking of Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
    Nezhat, Farr R.
    Denoble, Shaghayegh M.
    Cho, Jennifer E.
    Brown, Douglas N.
    Soto, Enrique
    Chuang, Linus
    Gretz, Herbert
    Saharia, Prakash
    JSLS-JOURNAL OF THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS, 2012, 16 (04) : 511 - 518
  • [33] Trends in stage at diagnosis for ovarian, fallopian tube, and serous primary peritoneal cancers, 2004-2015.
    Townsend, Julie S.
    Puckett, Mary C.
    Stewart, Sherri L.
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 103 - 104
  • [34] Serous ovarian, fallopian tube and primary peritoneal cancers: A common disease or separate entities - A systematic review
    Sorensen, Rie D.
    Schnack, Tine H.
    Karlsen, Mona A.
    Hogdall, Claus K.
    GYNECOLOGIC ONCOLOGY, 2015, 136 (03) : 571 - 581
  • [35] Frequency of genetic testing of patients with ovarian, fallopian tube, and primary peritoneal cancers: Quality improvement initiative
    Nawlo, Jude
    Espino, Kevin
    Gerber, Deanna
    Chan, Kent
    Jimenez, Edward
    Chalas, Eva
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S270 - S271
  • [36] Comment on "Primary Chemotherapy for Inoperable Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without Delayed Debulking Surgery"
    Barton, Desmond P. J.
    Naik, Rajan
    Pomel, Christophe
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (07) : 1104 - 1105
  • [37] PROGNOSTIC FEATURES OF SEROUS EPITHELIAL OVARIAN, FALLOPIAN TUBE, AND PERITONEAL CANCERS IN A POPULATION BASED SAMPLE
    Matsuno, R. K.
    Grimley, P. M.
    Goodman, M. T.
    Visvanathan, K.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 : S58 - S58
  • [38] Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian, and primary peritoneal carcinomas
    Takahiro, E.
    Kodaira, M.
    Shimoi, T.
    Shimomura, A.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Tamura, K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S547 - S547
  • [39] Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study
    Shibutani, Takashi
    Nagao, Shoji
    Suzuki, Kazuhiro
    Kaneda, Michiko
    Yamamoto, Kasumi
    Jimi, Tomoatsu
    Yano, Hiroko
    Kitai, Miho
    Shiozaki, Takaya
    Matsuoka, Kazuko
    Sudo, Tamotsu
    Yamaguchi, Satoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (03) : 502 - 507
  • [40] Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study
    Takashi Shibutani
    Shoji Nagao
    Kazuhiro Suzuki
    Michiko Kaneda
    Kasumi Yamamoto
    Tomoatsu Jimi
    Hiroko Yano
    Miho Kitai
    Takaya Shiozaki
    Kazuko Matsuoka
    Tamotsu Sudo
    Satoshi Yamaguchi
    International Journal of Clinical Oncology, 2020, 25 : 502 - 507
12345